Biogen CEO Chris Viehbacher and Travis Murdoch — fellow Canadians — hit it off when Biogen last year bought Murdoch's HI-Bio ...

The startup is advancing a drug licensed from China’s Hengrui Pharma that it claims could be “best-in-class” among a group of ...

Pfizer Inc. upped its original $7.3 billion September offer to buy Metsera Inc., but the obesity specialist maintained that a now-improved unsolicited bid by semaglutide developer Novo Nordisk A/S is ...

Gingko Bioworks is extending a partnership agreement with Bayer to continue developing microbial nitrogen fixation ...

Colossal Bioscences acquired Austin-based company, Viagen Pets and Equine, “the global leader and expert in animal cloning.” ...

Colossal Biosciences has expanded its efforts to save animals currently on the brink with its acquisition of the cloning ...

A North Carolina biotech whose backers included Bayer is closing, leaving questions about the future of its crop protection ...

To truly deliver on their promise, nitrogen-fixing microbes need to up their game, says Ginkgo ag bio head, Michael Miile.

Bayer remains a major partner for Ginkgo’s expanded agricultural biologicals platform, which includes the company’s Agriculture Biologicals Research & Development site in West Sacramento. The ...

Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to ...

According to MarketsandMarkets™, The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 ...

The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, ...